Table 5.
Visits | Liztox® Group | Botox® Group | p-Value | |||||
---|---|---|---|---|---|---|---|---|
n | Mean ± SD | Median [Min, Max] |
n | Mean ± SD | Median [Min, Max] |
|||
Total | ||||||||
4 weeks | 84 | −1.19 ± 0.67 | −1.00 [−2.00, 1.00] |
82 | −1.13 ± 0.72 | −1.00 [−2.00, 0.00] |
0.6045 | |
8 weeks | 82 | −1.12 ± 0.69 | −1.00 [−2.00, 1.00] |
79 | −1.09 ± 0.72 | −1.00 [−2.00, 1.00] |
0.6881 | |
12 weeks | 81 | −1.14 ± 0.68 | −1.00 [−3.00, 1.00] |
80 | −0.85 ± 0.60 | −1.00 [−2.00, 1.00] |
0.0047 * | |
Hand hygiene | ||||||||
4 weeks | 18 | −1.39 ± 0.50 | −1.00 [−2.00, 1.00] |
17 | −1.24 ± 0.66 | −1.00 [−2.00, 0.00] |
0.5454 | |
8 weeks | 18 | −1.39 ± 0.61 | −1.00 [−2.00, 0.00] |
17 | −1.12 ± 0.70 | −1.00 [−2.00, 0.00] |
0.2486 | |
12 weeks | 18 | −1.39 ± 0.61 | −1.00 [−3.00, −1.00] |
17 | −0.76 ± 0.56 | −1.00 [−2.00, 0.00] |
0.0048 * | |
Dressing | ||||||||
4 weeks | 2 | −1.50 ± 0.71 | −1.50 [−2.00, −1.00] |
3 | −0.67 ± 1.15 | 0.00 [−2.00, 0.00] |
0.5428 | |
8 weeks | 2 | −1.50 ± 0.71 | −1.50 [−2.00, −1.00] |
3 | −0.67 ± 1.15 | 0.00 [−2.00, 0.00] |
0.5428 | |
12 weeks | 2 | −1.00 ± 1.41 | −1.00 [−2.00, 0.00] |
2 | −1.00 ± 1.41 | −1.00 [−2.00, 0.00] |
1.0000 | |
Limb position | ||||||||
4 weeks | 61 | −1.16 ± 0.69 | −1.00 [−2.00, 1.00] |
58 | −1.16 ± 0.72 | −1.00 [−2.00, 0.00] |
0.9348 | |
8 weeks | 59 | −1.05 ± 0.71 | −1.00 [−2.00, 1.00] |
56 | −1.13 ± 0.72 | −1.00 [−2.00, 1.00] |
0.6246 | |
12 weeks | 58 | −1.05 ± 0.69 | −1.00 [−2.00, 1.00] |
57 | −0.88 ± 0.60 | −1.00 [−2.00, 1.00] |
0.1289 | |
Pain | ||||||||
4 weeks | 3 | −0.33 ± 0.58 | 0.00 [−1.00, 0.00] |
4 | −0.75 ± 0.50 | −1.00 [−1.00, 0.00] |
0.4142 | |
8 weeks | 3 | −0.67 ± 0.58 | −1.00 [−1.00, 0.00] |
3 | −0.67 ± 0.58 | −1.00 [−1.00, 0.00] |
1.0000 | |
12 weeks | 3 | −1.33 ± 0.58 | −1.00 [−2.00, −1.00] |
4 | −0.75 ± 0.50 | −1.00 [−1.00, 0.00] |
0.2703 |
Change = week 4, 8, 12—baseline. p-value for comparisons between treatment groups: Wilcoxon rank sum test. * The level of significance was set at p < 0.05